A fully liquid DTaP-IPV-Hep B-PRP-T hexavalent vaccine for primary and booster vaccination of healthy Mexican children

► Consistency of 3 lots of Hexaxim was demonstrated. ► Good immunogenicity following Hexaxim 2, 4, 6 month primary series, similar to control. ► High degree of antibody persistence at 15-18 months of age. ► Strong immune response following Hexaxim booster. ► No safety concerns for primary series or booster vaccinations.